Study Design Highlights Models: Caco-2 intestinal cell model, animal intestinal function model, human crossover RCT Human dose: 50 mg APS with L-arginine (single dose crossover) Outcomes: L-arginine absorption and bioavailability, amino acid transport pathway activity, intestinal structure and function markers Key Findings (What the Study Showed) Caco-2 model: Dose-dependent increases in L-arginine movement across the intestinal lining, associated with increased activity of amino acid transport pathways Animal models: Improvements in markers related to intestinal condition and physiological resilience during periods of stress
Any claims about synergistic fat-loss effects from combining these agents are not supported by peer-reviewed clinical evidence
In December 2023, a new study reported that in patients who had cardiovascular disease and obesity, but not diabetes, semaglutide was able to reduce the risk of heart attack, stroke, or death by 20%
Protein and lots of it
Compounding of medications is regulated by the FDA and state boards of pharmacy and the compounding pharmacy is required to adhere to state and federal laws
Sam Rhee: I'm really interested to see what your second cycle's like